If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
35
Followers on Owler
Nodality
a biotechnology company, focuses on hematological malignancies and autoimmune disorders...
Read more
Overview
Competitors
Funding
News & Insights
Nodality
a biotechnology company, focuses on hematological malignancies and autoimmune disorders...
Read more
CEO
Add
CEO Approval Rating
- -/100
01/2003
South San Francisco
California
San Francisco Bay Area
Private
Health Care Equipment & Services
Pharmaceuticals & Biotechnology
Pharmaceuticals
http://www.nodalityinc.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$70.1M
News
Latest News
Jan 09, 2017
BioPortfolio
Nodality, Inc.: Nodality Inc. Medical Equipment Deals and Alliances Profile Prices from USD $250
Jul 20, 2015
PR-INSIDE.COM
Press Release: Nodality : Nodality, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Market Report
Jul 09, 2015
PE HUB
Nodality: Nodality names LaPorte its CEO
Jul 08, 2015
BIOSPACE
Nodality, Inc.: Nodality, Inc. Appoints As Chief Executive Officer
Jul 08, 2015
BUSINESS WIRE
Press Release: Nodality : Nodality, Inc. Appoints Kathleen LaPorte as Chief Executive Officer
Jul 07, 2015
BUSINESS WIRE
Press Release: Nodality, Inc. : Nodality, Inc. Appoints Kathleen LaPorte as Chief Executive Officer
May 06, 2015
BUSINESS WIRE
Press Release: Nodality, Inc. : Nodality Launches PathPro T Cell Receptor (TCR) and B Cell Receptor (BCR) Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells
May 05, 2015
BIOPORTFOLIO
Nodality: Nodality Launches PathPro T Cell Receptor TCR and B Cell Receptor BCR Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells
May 05, 2015
BIOSPACE
Nodality, Inc.: Nodality, Inc. Launches Pathpro T Cell Receptor (TCR) And B Cell Receptor (BCR) Panels For Assessing Drug Impact On Functional Signaling In Primary Human Cells
Apr 21, 2015
SYS-CON MEDIA
Nodality, Inc.: Nodality Publishes Study Results Confirming the Company's Diagnostic Can Predict Induction Therapy Response in Elderly Patients with Acute Myeloid Leukemia
Follow and Get Alerts
Nodality Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 7 + competitors
Trending Companies